Physician profile
Ivan C Ketter
NPI 1194724500
$577.17
in general payments reported to CMS, 2019-2025
18 companies · $37.63 in 2025
The $37.63 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.45 · 2021: $87.34 · 2022: $132 · 2023: $149 · 2024: $159 · 2025: $37.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $172.84 | 2021-2024 | |
| Pfizer INC. | $51.85 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $39.90 | 2022-2023 | Eliquis |
| Amgen INC. | $34.17 | 2024 | Otezla, Repatha |
| Abbott Laboratories | $28.86 | 2022-2023 | Freestyle Libre 2 |
| Saluda Medical Americas, INC. | $28.83 | 2024 | Evoke |
| Astrazeneca Pharmaceuticals Lp | $27.89 | 2023 | Breztri |
| Takeda Pharmaceuticals U.S.A., INC. | $26.78 | 2023-2024 | Trintellix |
| Novo Nordisk INC | $26.37 | 2022 | |
| Novartis Pharmaceuticals Corporation | $21.32 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $18.92 | 2025 | Austedo Xr |
| Lilly USA, LLC | $18.71 | 2025 | Mounjaro |
| Janssen Pharmaceuticals, INC | $16.01 | 2022 | |
| Ascensia Diabetes Care US INC. | $15.48 | 2024 | |
| Mylan Specialty L.P. | $13.50 | 2023 | Yupelri |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.45 | 2020 | |
| Supernus Pharmaceuticals, INC. | $11.86 | 2021 | |
| Dynavax Technologies Corporation | $11.43 | 2023 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Ketter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.